temozolomide has been researched along with Nasopharyngeal Carcinoma in 2 studies
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nasopharyngeal carcinoma is a rare but highly invasive cancer." | 1.39 | PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy. ( Chen, H; Cheung, F; Chow, JP; Li Lung, M; Man, WY; Mao, M; Nicholls, J; Poon, RY; Tsao, SW, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, JP | 1 |
| Man, WY | 1 |
| Mao, M | 1 |
| Chen, H | 1 |
| Cheung, F | 1 |
| Nicholls, J | 1 |
| Tsao, SW | 1 |
| Li Lung, M | 1 |
| Poon, RY | 1 |
| Chen, TC | 1 |
| Cho, HY | 1 |
| Wang, W | 1 |
| Wetzel, SJ | 1 |
| Singh, A | 1 |
| Nguyen, J | 1 |
| Hofman, FM | 1 |
| Schönthal, AH | 1 |
2 other studies available for temozolomide and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Carcinoma; Cell Line; Cell Proliferation; Combined Moda | 2013 |
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo.
Topics: Animals; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Mice; Mice | 2015 |